Advertisement
Screener

PURE Bioscience, Inc. (PURE) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

1.8 / 5 stars · 28/78 Roast Me

PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 145.17% for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-15.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-06-15

  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-10-31 was 145.17%, a 22.52% increase year-over-year.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-04-30 was 125.48%.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-10-31 was 118.49%, a 6.80% increase year-over-year.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-10-31 was 110.95%, a 20.73% increase year-over-year.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 121.00%, a 9.06% increase from fiscal 2024.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 110.95%, a 20.73% increase from fiscal 2023.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 91.90%, a 4.02% increase from fiscal 2022.
  • PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 88.35%, a 0.67% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 1 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed
2026-04-30145.17%
10-Q · filed 2026-06-15
2026-01-31145.17%
10-Q · filed 2026-03-17
2025-10-31145.17%
10-Q · filed 2025-12-15
2025-07-31121.00%
10-K · filed 2025-10-29
2025-04-30125.48%
10-Q · filed 2025-06-16
118.49%
10-Q · filed 2026-06-15
2025-01-31118.49%
10-Q · filed 2026-03-17
2024-10-31118.49%
10-Q · filed 2025-12-15
2024-07-31110.95%
10-K · filed 2025-10-29
2024-04-30110.95%
10-Q · filed 2025-06-16
2024-01-31110.95%
10-Q · filed 2025-03-17
2023-10-31110.95%
10-Q · filed 2024-12-16
2023-07-3191.90%
10-K · filed 2024-10-29
2023-04-3091.90%
10-Q · filed 2024-06-14
2023-01-3191.90%
10-Q · filed 2024-03-18
2022-10-3191.90%
10-Q · filed 2023-12-14
2022-07-3188.35%
10-K · filed 2023-10-30
2022-04-3088.35%
10-Q · filed 2023-06-14
2022-01-3190.26%
10-Q · filed 2022-03-15
88.35%
10-Q · filed 2023-03-17
2021-10-3185.61%
10-Q · filed 2022-12-14
2021-07-3187.76%
10-K · filed 2022-10-28
2021-04-30104.93%
10-Q · filed 2022-06-14
2021-01-31104.93%
10-Q · filed 2022-03-15
104.93%
10-Q · filed 2022-03-15
2020-10-310.00%
10-Q · filed 2020-12-15
2020-07-3183.15%
10-K · filed 2021-10-28
2020-04-300.00%
10-Q · filed 2020-06-11
79.48%
10-Q · filed 2021-06-15
2020-01-3179.48%
10-Q · filed 2021-03-15
79.62%
10-Q · filed 2021-03-15
2019-10-3179.16%
10-Q · filed 2020-12-15
2019-07-3175.67%
10-K · filed 2020-10-08
2019-04-3082.24%
10-Q · filed 2020-06-11
75.67%
10-Q · filed 2020-06-11
2019-01-310.00%
10-Q · filed 2020-03-12
62.52%
10-Q · filed 2020-03-12
2018-10-3162.52%
10-Q · filed 2019-12-13
2018-07-3171.80%
10-K · filed 2019-10-30
71.18%
10-K · filed 2018-10-25
2018-04-3066.33%
10-Q · filed 2019-06-13
70.16%
10-Q · filed 2019-06-13
2018-01-3184.89%
10-Q · filed 2019-03-06
85.94%
10-Q · filed 2019-03-06
2017-10-3186.98%
10-Q · filed 2018-12-13
2017-07-3181.00%
10-K · filed 2018-10-25
2017-04-3074.10%
10-Q · filed 2018-06-13
74.13%
10-Q · filed 2018-06-13
2017-01-310.00%
10-Q · filed 2018-03-14
74.71%
10-Q · filed 2018-03-14
2016-10-3174.71%
10-Q · filed 2017-12-14
2016-07-3182.12%
10-K · filed 2017-10-26
2016-04-3082.36%
10-Q · filed 2017-06-08
84.20%
10-Q · filed 2017-06-08
2016-01-3196.60%
10-Q · filed 2017-03-02
96060.00%
10-Q · filed 2017-03-02
2014-07-31108.00%
10-K · filed 2015-10-28
2014-04-30154.07%
10-Q · filed 2015-06-11
2013-07-31134.80%
10-K · filed 2014-10-28
2013-04-30134.80%
10-Q · filed 2013-06-14
2013-04-24140.75%
10-Q · filed 2013-06-14
140.75%
10-K · filed 2013-10-24
2013-04-17140.63%
10-Q · filed 2013-06-14
140.63%
10-K · filed 2013-10-24
2013-01-31134.66%
10-Q · filed 2013-02-25
2012-07-3185.41%
10-K · filed 2013-10-24
2012-06-2982.44%
10-K · filed 2013-10-24
2012-04-3081.59%
10-Q · filed 2013-06-14
2012-01-3194.20%
10-Q · filed 2013-02-25